IntoCell Employee Directory

IntoCell corporate office is located in 101 Shinildong-ro Daedeok-gu, Daejeon, 34324, South Korea and has 11-50 employees.

Key Employees of IntoCell

  • YR
    South Korea flag for contact location.
    Yosup Rew

    Chief Technology Officer & Executive Vice Presiden...

    PhonePhoneEmailEmail
  • PE
    South Korea flag for contact location.
    Paul Edelmann

    President

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

IntoCell Global Presence

globalPresence illustration
North America1-10
Asia1-10

Index of contact profiles from IntoCell

Hundreds of professionals searching for IntoCell have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

Former Employees at IntoCell

Explore people who held key positions, contributed to IntoCell's success, and advanced their careers.

  1. Chief Technology Offic... at ABL Bio

    Worked as Senior Vice President, CSO

    at IntoCell (2021-2025)

    email Sung-Ju Moon Email direct Sung-Ju Moon Direct
  2. Director, Research Dev... at Rophibio

    Worked as Team Lead

    at IntoCell (2019-2021)

    email Young-Jae Eu Email direct Young-Jae Eu Direct

Explore More

Frequently Asked Questions Regarding IntoCell Employees

How many employees does IntoCell have?
IntoCell has 11-50 employees
Who are IntoCell key employees?
Some of IntoCell key employees are Yosup Rew, Paul Edelmann
Where is IntoCell located?
IntoCell’s headquarters are located at 101 Shinildong-ro Daedeok-gu, Daejeon, 34324, South Korea
How do I contact IntoCell?
IntoCell Contact Info: Phone number: +82 427160083 Website: www.intocell.co.kr
What does IntoCell do?

IntoCell is a Korea-based biotechnology company dedicated to the development and commercialisation of novel ADC platform technologies comprising scaffold moiety, ligands, toxins, linkers and conjugation methods. In addition to its OHPAS linker, the company has also successfully developed and tested its own proprietary benzodiazepines (BD) to overco... me the challenges of existing BD toxins including their lack of conjugatable functional groups and their poor aqueous solubility. IntoCell is currently seeking research and development partners interested in licensing its ADC platform technologies. It is open to discussing exploratory pilot and feasibility studies for its cleavage chemistry focused linker technology and its novel benzodiazepine payloads.Read More

Is IntoCell a public company?
IntoCell is private company therefore does not currently have an official ticker symbol
See more information about IntoCell Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.